Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
Sabrina Zulfikar, Sarah Mulholland, Huzaifa Adamali, Shaney L Barratt Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UKCorrespondence: Shaney L BarrattConsultant Respiratory Physician and Honorary Associate Researcher, North Bristol NHS Trust, Southmead Hospital, Southm...
Guardado en:
Autores principales: | Zulfikar S, Mulholland S, Adamali H, Barratt SL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d1c78ca5bdc493db7ac55a1f103b686 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Design and Development of Autotaxin Inhibitors
por: Yi Jia, et al.
Publicado: (2021) -
Disrupted Blood‐Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
por: Susmita Bhattarai, et al.
Publicado: (2021) -
Enfermedades pulmonares intersticiales. Una perspectiva actual
por: SALINAS,MAURICIO, et al.
Publicado: (2019) -
Interstitial lung abnormalities – current knowledge and future directions
por: Gisli Thor Axelsson, et al.
Publicado: (2021) -
Autotaxin May Have Lysophosphatidic Acid-Unrelated Effects on Three-Dimension (3D) Cultured Human Trabecular Meshwork (HTM) Cells
por: Megumi Watanabe, et al.
Publicado: (2021)